Cargando…
Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide
BACKGROUND: Hypertension is, amongst others, characterized by endothelial dysfunction and vascular remodeling. As sphingolipids have been implicated in both the regulation of vascular contractility and growth, we investigated whether sphingolipid biology is altered in hypertension and whether this i...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139577/ https://www.ncbi.nlm.nih.gov/pubmed/21818267 http://dx.doi.org/10.1371/journal.pone.0021817 |
_version_ | 1782208471426400256 |
---|---|
author | Spijkers, Léon J. A. van den Akker, Rob F. P. Janssen, Ben J. A. Debets, Jacques J. De Mey, Jo G. R. Stroes, Erik S. G. van den Born, Bert-Jan H. Wijesinghe, Dayanjan S. Chalfant, Charles E. MacAleese, Luke Eijkel, Gert B. Heeren, Ron M. A. Alewijnse, Astrid E. Peters, Stephan L. M. |
author_facet | Spijkers, Léon J. A. van den Akker, Rob F. P. Janssen, Ben J. A. Debets, Jacques J. De Mey, Jo G. R. Stroes, Erik S. G. van den Born, Bert-Jan H. Wijesinghe, Dayanjan S. Chalfant, Charles E. MacAleese, Luke Eijkel, Gert B. Heeren, Ron M. A. Alewijnse, Astrid E. Peters, Stephan L. M. |
author_sort | Spijkers, Léon J. A. |
collection | PubMed |
description | BACKGROUND: Hypertension is, amongst others, characterized by endothelial dysfunction and vascular remodeling. As sphingolipids have been implicated in both the regulation of vascular contractility and growth, we investigated whether sphingolipid biology is altered in hypertension and whether this is reflected in altered vascular function. METHODS AND FINDINGS: In isolated carotid arteries from spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats, shifting the ceramide/S1P ratio towards ceramide dominance by administration of a sphingosine kinase inhibitor (dimethylsphingosine) or exogenous application of sphingomyelinase, induced marked endothelium-dependent contractions in SHR vessels (DMS: 1.4±0.4 and SMase: 2.1±0.1 mN/mm; n = 10), that were virtually absent in WKY vessels (DMS: 0.0±0.0 and SMase: 0.6±0.1 mN/mm; n = 9, p<0.05). Imaging mass spectrometry and immunohistochemistry indicated that these contractions were most likely mediated by ceramide and dependent on iPLA(2), cyclooxygenase-1 and thromboxane synthase. Expression levels of these enzymes were higher in SHR vessels. In concurrence, infusion of dimethylsphingosine caused a marked rise in blood pressure in anesthetized SHR (42±4%; n = 7), but not in WKY (−12±10%; n = 6). Lipidomics analysis by mass spectrometry, revealed elevated levels of ceramide in arterial tissue of SHR compared to WKY (691±42 vs. 419±27 pmol, n = 3–5 respectively, p<0.05). These pronounced alterations in SHR sphingolipid biology are also reflected in increased plasma ceramide levels (513±19 pmol WKY vs. 645±25 pmol SHR, n = 6–12, p<0.05). Interestingly, we observed similar increases in ceramide levels (correlating with hypertension grade) in plasma from humans with essential hypertension (185±8 pmol vs. 252±23 pmol; n = 18 normotensive vs. n = 19 hypertensive patients, p<0.05). CONCLUSIONS: Hypertension is associated with marked alterations in vascular sphingolipid biology such as elevated ceramide levels and signaling, that contribute to increased vascular tone. |
format | Online Article Text |
id | pubmed-3139577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-31395772011-08-04 Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide Spijkers, Léon J. A. van den Akker, Rob F. P. Janssen, Ben J. A. Debets, Jacques J. De Mey, Jo G. R. Stroes, Erik S. G. van den Born, Bert-Jan H. Wijesinghe, Dayanjan S. Chalfant, Charles E. MacAleese, Luke Eijkel, Gert B. Heeren, Ron M. A. Alewijnse, Astrid E. Peters, Stephan L. M. PLoS One Research Article BACKGROUND: Hypertension is, amongst others, characterized by endothelial dysfunction and vascular remodeling. As sphingolipids have been implicated in both the regulation of vascular contractility and growth, we investigated whether sphingolipid biology is altered in hypertension and whether this is reflected in altered vascular function. METHODS AND FINDINGS: In isolated carotid arteries from spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats, shifting the ceramide/S1P ratio towards ceramide dominance by administration of a sphingosine kinase inhibitor (dimethylsphingosine) or exogenous application of sphingomyelinase, induced marked endothelium-dependent contractions in SHR vessels (DMS: 1.4±0.4 and SMase: 2.1±0.1 mN/mm; n = 10), that were virtually absent in WKY vessels (DMS: 0.0±0.0 and SMase: 0.6±0.1 mN/mm; n = 9, p<0.05). Imaging mass spectrometry and immunohistochemistry indicated that these contractions were most likely mediated by ceramide and dependent on iPLA(2), cyclooxygenase-1 and thromboxane synthase. Expression levels of these enzymes were higher in SHR vessels. In concurrence, infusion of dimethylsphingosine caused a marked rise in blood pressure in anesthetized SHR (42±4%; n = 7), but not in WKY (−12±10%; n = 6). Lipidomics analysis by mass spectrometry, revealed elevated levels of ceramide in arterial tissue of SHR compared to WKY (691±42 vs. 419±27 pmol, n = 3–5 respectively, p<0.05). These pronounced alterations in SHR sphingolipid biology are also reflected in increased plasma ceramide levels (513±19 pmol WKY vs. 645±25 pmol SHR, n = 6–12, p<0.05). Interestingly, we observed similar increases in ceramide levels (correlating with hypertension grade) in plasma from humans with essential hypertension (185±8 pmol vs. 252±23 pmol; n = 18 normotensive vs. n = 19 hypertensive patients, p<0.05). CONCLUSIONS: Hypertension is associated with marked alterations in vascular sphingolipid biology such as elevated ceramide levels and signaling, that contribute to increased vascular tone. Public Library of Science 2011-07-19 /pmc/articles/PMC3139577/ /pubmed/21818267 http://dx.doi.org/10.1371/journal.pone.0021817 Text en Spijkers et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Spijkers, Léon J. A. van den Akker, Rob F. P. Janssen, Ben J. A. Debets, Jacques J. De Mey, Jo G. R. Stroes, Erik S. G. van den Born, Bert-Jan H. Wijesinghe, Dayanjan S. Chalfant, Charles E. MacAleese, Luke Eijkel, Gert B. Heeren, Ron M. A. Alewijnse, Astrid E. Peters, Stephan L. M. Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide |
title | Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide |
title_full | Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide |
title_fullStr | Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide |
title_full_unstemmed | Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide |
title_short | Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide |
title_sort | hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139577/ https://www.ncbi.nlm.nih.gov/pubmed/21818267 http://dx.doi.org/10.1371/journal.pone.0021817 |
work_keys_str_mv | AT spijkersleonja hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT vandenakkerrobfp hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT janssenbenja hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT debetsjacquesj hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT demeyjogr hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT stroeseriksg hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT vandenbornbertjanh hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT wijesinghedayanjans hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT chalfantcharlese hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT macaleeseluke hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT eijkelgertb hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT heerenronma hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT alewijnseastride hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide AT petersstephanlm hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide |